Browse EX-10 agreements

CHANGE OF CONTROL SEVERANCE AGREEMENT

This CHANGE OF CONTROL SEVERANCE AGREEMENT (the “Agreement”), is made as of the 1stday of October, 2026 (the “Effective Date”), by and between THE GORMAN-RUPP COMPANY, an Ohio corporation (the “Company”), and Scott A. King (the “Executive”).

WHEREAS, the Company desires to enter into an agreement with the Executivein recognition of the importance of the Executive’s services to the continuity of management of the Company and based upon its determination that it will be in the best interests of the Company to encourage the Executive’s continued attention and dedication to the Executive’s duties in the potentially disruptive circumstances of a possible Change of Control of the Company. As used in this Agreement, the term “Change of Control” and certain other capitalized terms have the meanings ascribed to them in Section 8 hereof.

NOW, THEREFORE, in consideration of the promises and mutual covenants contained herein, the parties agree as follows:

1.

…

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT, dated as of October 1, 2026, is by and between SCIENTIFIC INDUSTRIES, INC., a Delaware corporation with its principal executive offices at 80 Orville Drive, Suite 102, Bohemia, New York, 11716 (the “Company”) and ZACHARY ROVINSKY, an individual residing at 4 Netto Lane, Plainview, NY 11803 (“Employee”).

W I T N E S S E T H:

WHEREAS, the Company desires to continue to employ Employee as a senior executive of the Company, and Employee desires to continue to serve in such capacity, all on the terms and conditions set forth below.

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:

…

EXHIBIT 10.3

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT

This Amendment No. 2 to the Employment Agreement between Scientific Bioprocessing, Inc. (the “Company”) and John Moore (“Employee”) is made this 1st day of October, 2026 (“Amendment”). The Company and Employee are hereinafter collectively referred to as the “Parties.”

WHEREAS, the Company and Employee are parties to an existing Employment Agreement, dated July 1, 2020, as amended by that certain Amendment No. 1 to Employment Agreement dated as of May 20, 2025 (as amended, the “Agreement”);

WHEREAS, the Term (as defined in the Agreement and extended through amendment) expired on June 30, 2026 and has since continued on the terms set forth in the Agreement; and

WHEREAS, the Parties wish to amend the Agreement to provide for an additional extension of the Term of the Agreement, as set forth in this Amendment.

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the Parties, intending to be legally bound, agree as follows.

1. Recitals. The above recitals are incorporated herein.

…

AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENT

This Amendment No. 3 to the Employment Agreement between Scientific Industries, Inc. (the “Company”) and Helena Santos (“Employee”) is made this 1st day of October, 2026 (“Amendment”). The Company and Employee are hereinafter collectively referred to as the “Parties.”

WHEREAS, the Company and Employee are parties to that certain Employment Agreement, dated July 1, 2017, as amended by that certain Amendment No. 1 to Employment Agreement, dated as of June 23, 2022 and Amendment No. 2 to Employment Agreement dated May 20, 2025 (as amended, the “Agreement”);

WHEREAS, the Term (as defined in the Agreement and extended by amendment) expired on June 30, 2026 and has since continued on the terms set forth in the Agreement; and

WHEREAS, pursuant to Section 18 of the Agreement, the Parties wish to amend the Agreement to provide for an additional extension of the Term of the Agreement, as set forth in this Amendment.

…

CNS PHARMACEUTICALS, INC.

2020 EQUITY PLAN

(Amended and Restated)

______________________

Section 1.	Establishment and Purpose.

1.1 The Board of Directors of CNS Pharmaceuticals, Inc. (the “Company”) established the CNS Pharmaceuticals, Inc. 2020 Equity Plan (the “Plan”) effective as of April 6, 2020, which was approved by the Company’s stockholders at the Company’s annual meeting on June 8, 2020. The Plan was amended effective as of August 9, 2023, as of March 26, 2024, and on November 17, 2025 and on September 30, 2026, subject to approval by the Company’s stockholders at the Company’s annual meeting on September 30, 2026.

…

Second Amendment to Registration Rights Agreement

** **

**This Second Amendment to the Registration Rights Agreement **(the “Amendment”), dated as of September 28, 2026, is made by and between BNB Plus Corp., a Delaware corporation (“Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). The parties hereto are referred to collectively as the “Parties” and individually as a “Party”.

Whereas, the Parties have entered into that certain Registration Rights Agreement dated as of May 26, 2026, amended by the first amendment dated June 23, 2026 (the “Agreement”);

Whereas, pursuant to Section 6(d) of the Agreement, the Parties desire to amend the Agreement to replace the mandatory registration rights with demand registration rights as more fully described herein;

Whereas, the Purchasers hereto hold 50.1% or more of the Registrable Securities.

…

This Promissory Note (this “Note”) and the securities issuable upon conversion of this Note pursuant to the terms hereof have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws and neither this note, such securities nor any interest therein may be offered, sold, transferred, pledged or otherwise disposed of except pursuant to an effective registration statement under such act or such laws or an exemption from registration under such act and such laws which, in the opinion of counsel for maker, is available.

** **

CONVERTIBLE PROMISSORY NOTE

** **

Principal Amount: $25,000	Dated as of August 30, 2026

** **

…

This Promissory Note (this “Note”) and the securities issuable upon conversion of this Note pursuant to the terms hereof have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws and neither this note, such securities nor any interest therein may be offered, sold, transferred, pledged or otherwise disposed of except pursuant to an effective registration statement under such act or such laws or an exemption from registration under such act and such laws which, in the opinion of counsel for maker, is available.

** **

CONVERTIBLE PROMISSORY NOTE

** **

Principal Amount: $25,000	Dated as of September 30, 2026

** **

…

This Promissory Note (this “Note”) and the securities issuable upon conversion of this Note pursuant to the terms hereof have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws and neither this note, such securities nor any interest therein may be offered, sold, transferred, pledged or otherwise disposed of except pursuant to an effective registration statement under such act or such laws or an exemption from registration under such act and such laws which, in the opinion of counsel for maker, is available.

** **

CONVERTIBLE PROMISSORY NOTE

** **

Principal Amount: $50,000	Dated as of September 22, 2026

…

This Promissory Note (this “Note”) and the securities issuable upon conversion of this Note pursuant to the terms hereof have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws and neither this note, such securities nor any interest therein may be offered, sold, transferred, pledged or otherwise disposed of except pursuant to an effective registration statement under such act or such laws or an exemption from registration under such act and such laws which, in the opinion of counsel for maker, is available.

** **

CONVERTIBLE PROMISSORY NOTE

** **

Principal Amount: $25,000	Dated as of September 30, 2026

** **

…

This Promissory Note (this “Note”) and the securities issuable upon conversion of this Note pursuant to the terms hereof have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws and neither this note, such securities nor any interest therein may be offered, sold, transferred, pledged or otherwise disposed of except pursuant to an effective registration statement under such act or such laws or an exemption from registration under such act and such laws which, in the opinion of counsel for maker, is available.

** **

CONVERTIBLE PROMISSORY NOTE

** **

Principal Amount: $50,000	Dated as of September 22, 2026

…

This Promissory Note (this “Note”) and the securities issuable upon conversion of this Note pursuant to the terms hereof have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws and neither this note, such securities nor any interest therein may be offered, sold, transferred, pledged or otherwise disposed of except pursuant to an effective registration statement under such act or such laws or an exemption from registration under such act and such laws which, in the opinion of counsel for maker, is available.

** **

CONVERTIBLE PROMISSORY NOTE

** **

Principal Amount: $25,000	Dated as of August 30, 2026

** **

…